Engerix Vaccine B Paediatric Indications
Engerix Vaccine B Paediatric is primarily indicated in conditions like Hepatitis B prophylaxis, and can also be given in adjunctive therapy as an alternative drug of choice in Immunocompromised patient.
The severe or irreversible adverse effects of Engerix Vaccine B Paediatric, which give rise to further complications include Convulsions, Neuropathy, Angioedema, Angioedema, Meningitis, Anaphylactic reactions, Paralysis.,Engerix Vaccine B Paediatric produces potentially life-threatening effects which include Anaphylactic reactions. which are responsible for the discontinuation of Engerix Vaccine B Paediatric therapy.,The symptomatic adverse reactions produced by Engerix Vaccine B Paediatric are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness. Dizziness. Headache. Fatique. Nausea. Vomiting, Diarrhea, Fever, Myalgia, Abdominal pain, Rashes, Pruritus, Pain, Redness, Malaise, Hypotension, Arthralgia, Syncope, Paralysis, Paresthesias, Swelling at injection site, dizziness.
Engerix Vaccine B Paediatric is contraindicated in conditions like Hypersensitivity, Acute severe febrile illness.
Caution and appropriate care should be exercised in administering the vaccine to individuals with severely compromised cardiopulmonary status or to others in whom a febrile or systemic reaction could pose a significant risk. The healthcare provider should determine the current health status and previous vaccination history of the vaccinee.Injection of a blood vessel should be avoided.Dialysed or immonocompromised pateints may need further doses special caution during pregnancy.